Head of Commercial France & Benelux at Cytokinetics

Paris, Île-de-France, France

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, CardiovascularIndustries

Requirements

Extensive experience in pharmaceutical commercial leadership in France; knowledge of Benelux healthcare systems is a plus
Fluent in English
Minimum 10 years’ experience in pharmaceutical sales, marketing, or commercial leadership roles
Ideally experience in cardiology or rare diseases
Strong analytical and strategic thinking capabilities
Proven ability to lead, inspire, and drive high-performing teams

Responsibilities

Define and execute the commercial strategy for France & Benelux, aligned with global and European objectives
Represent the commercial function on the Country Leadership Team
Collaborate actively with Global, EU & local teams to share insights, benchmark performance, and implement best practices
Monitor market dynamics and competitor activity to inform strategic decisions
Develop and implement market research initiatives to inform strategy, track performance, and guide decision-making
Foster a culture of innovation, accountability, and patient-centricity
Ensure all commercial activities comply with the company’s Code of Conduct and local pharmaceutical regulations
Lead and manage the sales and marketing teams to achieve national and regional targets
Recruit, develop, manage, and retain a high-performing commercial organization (Sales Managers, Key Account Managers, Marketing)
Establish performance standards, CRM systems, KPIs, and incentive schemes
Drive a high-performance culture through coaching, development, and operational excellence
Oversee development and execution of integrated marketing campaigns, congress strategies, and educational initiatives
Manage external vendors and agencies to deliver high-impact programs
Ensure compliance with regulatory standards and internal SOPs
Own the France & Benelux commercial P&L, delivering on revenue and profitability targets
Manage budgets and resources effectively, ensuring alignment with launch and growth objectives
Track and analyze performance against forecasts and KPIs, adjusting strategy as needed
Act as company ambassador with key stakeholders (healthcare professionals, payers, regulators)
Engage directly with external stakeholders through customer-facing activities (joint visits, KOL meetings, congresses, and events)

Skills

Commercial Strategy

Sales Leadership

Marketing

Stakeholder Engagement

Team Leadership

Market Analysis

Product Launch

Cross-Functional Collaboration

Strategic Planning

Performance Benchmarking

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters

1998Year Founded

$58.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Risks

Increased competition could impact market share and profitability.

Potential delays in clinical trials could hinder drug commercialization.

Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.

The company has a robust pipeline including omecamtiv mecarbil and aficamten.

Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.

Strategic partnerships, like with Sanofi, expand market reach and potential revenue.

Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI

Try Jobo Free